EDR Peptide: Possible Mechanism of Gene Expression and Protein Synthesis Regulation Involved in the Pathogenesis of Alzheimer’s Disease
V. Khavinson, N. Linkova, E. Kozhevnikova, S. Trofimova · 2020 · Molecules 26(1):159; published December 31, 2020
What does this source report?
Reviews EDR/Pinealon mechanisms involving gene regulation, neuronal survival and oxidative-stress pathways. Its cited human reports need original-paper review; it is not a trial establishing Alzheimer’s treatment benefit.
- Population and setting
- Review of earlier research
- Evidence type
- Review
- Preparation
- See the original report; formulation details require verification.
- Source language
- English
- Title provenance
- Title as recorded in the linked source or index. A separate original-language title has not been transcribed unless shown above.
What are the limitations?
- Source-linked does not mean a completed risk-of-bias review.
- A review is not an independent clinical replication; proposed mechanisms do not establish efficacy or safety.
Publication counts are not counts of independent trials. Reviews, translations and reports sharing participants may overlap. Findings apply to the studied preparation, population and endpoints.
Source access and review scope
Source scope and bibliographic record checked; underlying experiments require individual appraisal.
Recorded source-check date: 2026-09-27. This date does not imply a completed systematic review.
Cite and trace this record
Original source: V. Khavinson, N. Linkova, E. Kozhevnikova, S. Trofimova. EDR Peptide: Possible Mechanism of Gene Expression and Protein Synthesis Regulation Involved in the Pathogenesis of Alzheimer’s Disease Molecules 26(1):159; published December 31, 2020 2020.
Molekul research summary: https://molekul.io/research/edr-2020-review. Cite the original publication for its findings and this page when referring to Molekul’s summary or evidence appraisal.
Bibliography entry